open access

Vol 25, No 1 (2022)
Clinical vignette
Submitted: 2021-08-30
Accepted: 2021-11-30
Published online: 2022-01-27
Get Citation

Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism

Vlatka Jozanovic1, Drazen Huic21
·
Pubmed: 35137941
·
Nucl. Med. Rev 2022;25(1):66-67.
Affiliations
  1. Clinical Department of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb
  2. The University of Zagreb School of Medicine, Zagreb, Croatia

open access

Vol 25, No 1 (2022)
Clinical vignette
Submitted: 2021-08-30
Accepted: 2021-11-30
Published online: 2022-01-27

Abstract

We present a case report of incidental detection of breast cancer in a female patient referred for 18F-fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) due to primary hyperparathyroidism. This imaging method was recently shown as more sensitive for the detection of metabolically hyperactive parathyroid glands than neck ultrasound and (2-metoksyizobutyloizonitryl labeled with technetium-99m) [99mTc]MIBI. Increased accumulation of FCH was found in the hyperactive parathyroid gland and unexpectedly in the right breast lesion. The surgery confirmed parathyroid adenoma. One month later right upper medial quadrantectomy confirmed breast carcinoma — a combination of invasive ductal carcinoma and intracystic papillary breast carcinoma. To the best of our knowledge, this is the first reporting of simultaneous detection of parathyroid adenoma and breast cancer by using 18F-fluorocholine PET/CT.

Abstract

We present a case report of incidental detection of breast cancer in a female patient referred for 18F-fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) due to primary hyperparathyroidism. This imaging method was recently shown as more sensitive for the detection of metabolically hyperactive parathyroid glands than neck ultrasound and (2-metoksyizobutyloizonitryl labeled with technetium-99m) [99mTc]MIBI. Increased accumulation of FCH was found in the hyperactive parathyroid gland and unexpectedly in the right breast lesion. The surgery confirmed parathyroid adenoma. One month later right upper medial quadrantectomy confirmed breast carcinoma — a combination of invasive ductal carcinoma and intracystic papillary breast carcinoma. To the best of our knowledge, this is the first reporting of simultaneous detection of parathyroid adenoma and breast cancer by using 18F-fluorocholine PET/CT.

Get Citation

Keywords

18F-fluorocholine PET/CT; breast cancer; primary hyperparathyroidism

About this article
Title

Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism

Journal

Nuclear Medicine Review

Issue

Vol 25, No 1 (2022)

Article type

Clinical vignette

Pages

66-67

Published online

2022-01-27

Page views

5611

Article views/downloads

413

DOI

10.5603/NMR.a2022.0013

Pubmed

35137941

Bibliographic record

Nucl. Med. Rev 2022;25(1):66-67.

Keywords

18F-fluorocholine PET/CT
breast cancer
primary hyperparathyroidism

Authors

Vlatka Jozanovic
Drazen Huic

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl